Duplication of leucyl-tRNA synthetase in an archaeal extremophile may play a role in adaptation to variable environmental conditions. Weitzel CS, Li L, Zhang C, Eilts KK, Bretz NM, Gatten AL, Whitaker RJ, Martinis SA.J Biol Chem. 2020 Apr 3;295(14):4563-4576. doi: 10.1074/jbc.RA118.006481. Epub 2020 Feb 26.PMID: 32102848Read Publication
Chancellor Collins to UMass Chan PhD candidates: ‘We need your science’
During the annual Recognition Ceremony, the Morningside Graduate School of Biomedical Sciences celebrated 74 PhD candidates and MD/PhD students who successfully completed their qualifying exam in 2024-2025.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Clinician, Faculty, Student, Michael F. Collins, Craig C. Mello, Research, Katherine Fitzgerald, Guangping Gao, Michelle Kelliher, Anastasia Khvorova, Dohoon Kim, Michael J. Lee, Stephenie Lemon, Arthur M. Mercurio, Paul R. Thompson, Wen Xue, Dan Wang, John Harris, Neurobiology, Phillip Zamore, Celia Schiffer, Latest News, Vanni Bucci, Brian Kelch, Erik Sontheimer, Athma Pai, Li Li, Mary Munson, Top Stories, Jessica Spinelli, Fiachra Humphries, Sy Redding, Sean Ryder, Matthew Hemming,
Jul 3, 2024
UMass Chan BRIDGE Fund commits $2M in six faculty projects
BRIDGE Innovation and Business Development at UMass Chan Medical School has set aside nearly $2 million in funding for six faculty-led research projects that hold promise for translation to clinical application and commercialization.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Faculty, Research, Sharon Cantor, Paul R. Thompson, Scot A. Wolfe, Cantor Lab, Wolfe Lab, Wang Lab, Dan Wang, Molecular, Cell and Cancer Biology, Biochemistry and Molecular Biotechnology, RNA Therapeutics Institute, Marcus Ruscetti, Latest News, Li Li, BRIDGE, Top Stories,
Apr 22, 2024
PhD candidate engineers new RNA sequences to enable mRNA-based therapeutics
PhD candidate Seden Bedir moved from Turkey to the U.S. to study at UMass Chan Medical School. She aims to engineer RNA sequences that don’t exist in nature in order to enable mRNA-based therapeutics beyond vaccines. In her free time, she mentors students from Turkey.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Faculty, Student, Education, Interdisciplinary, RNA Therapeutics Institute, Student Spotlight, Latest News, Li Li, Top Stories, Media,
Jan 8, 2024
Drugs of the future will be easier and faster to make, thanks to mRNA
UMass Chan researcher Li Li, PhD, writes for The Conversation about how mRNA drug development, which led to the first COVID-19 vaccine, offers significant advantages over traditional drug development.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Faculty, Research, Conversation, RNA Therapeutics Institute, Latest News, Li Li,
Sep 14, 2023
Sharing of knowledge, ideas celebrated during Qualifying Exam Recognition Ceremony
The UMass Chan community gathered to celebrate 53 PhD candidates and MD/PhD students who transitioned from student to candidate for a doctoral degree during the 2022-2023 academic year.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Faculty, Student, Education, MD/PhD, Terence Flotte, Michelle Kelliher, Pathology, RNA Therapeutics Institute, Latest News, Li Lab, Li Li, Top Stories,
